Phenergan

Anaphylaxis, Catarrh, Acute Bronchitis + 18 more
Treatment
6 FDA approvals
20 Active Studies for Phenergan

What is Phenergan

PromethazineThe Generic name of this drug
Treatment SummaryPromethazine is a medication used to treat allergies, pain, sedation, nausea, and vomiting. It was first developed in France in 1946 and approved by the FDA in 1951. Promethazine works by blocking certain receptors in the body, allowing it to work on a variety of indications.
Phenerganis the brand name
image of different drug pills on a surface
Phenergan Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Phenergan
Promethazine
1951
473

Approved as Treatment by the FDA

Promethazine, otherwise called Phenergan, is approved by the FDA for 6 uses such as Nasal Congestion and Acute Bronchitis .
Nasal Congestion
Used to treat Nasal Congestion in combination with Phenylephrine
Acute Bronchitis
Used to treat Cough in combination with Dextromethorphan
Hypersensitivity
Used to treat Allergic Reaction in combination with Codeine
Anaphylaxis
Catarrh
Used to treat Common Cold in combination with Codeine
upper respiratory symptoms
Used to treat upper respiratory symptoms in combination with Codeine

Effectiveness

How Phenergan Affects PatientsPromethazine is a medicine that helps to reduce pain, induce sleepiness, and treat allergies. The effects of the drug last for 4-6 hours, but may last up to 12 hours. Patients should be aware of the potential risks such as reduced alertness or breathing, increased risk of seizures, and decreased production of red blood cells.
How Phenergan works in the bodyPromethazine helps reduce allergic reactions, improve sleep, manage anxiety and tension, and reduce nausea and vomiting. It does this by blocking certain receptors in the body, including histamine H1, dopamine, alpha adrenergic, muscarinic, and NMDA receptors.

When to interrupt dosage

The suggested dosage of Phenergan is contingent upon the determined condition, including Hay Fever, Postoperative Pain and Acute Bronchitis. The amount of dosage is reliant on the approach of administration set out in the table below.
Condition
Dosage
Administration
Coughing
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Analgesics
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Motion Sickness
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
upper respiratory symptoms
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Rhinitis, Vasomotor
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Hay Fever
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Acute Bronchitis
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Allergic urticaria
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
perioperative nausea and vomiting
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Allergic Conjunctivitis (AC)
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Nausea
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Nasal Congestion
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Dermographism
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Airsickness
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Sedative therapy
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Postoperative Pain
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Hypersensitivity
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Anaphylaxis
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Hypersensitivity
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical
Catarrh
, 12.5 mg, 25.0 mg, 50.0 mg, 6.25 mg/mL, 25.0 mg/mL, 50.0 mg/mL, 0.25 mg, 0.5 mg/mL, 1.0 mg/mL, 0.625 mg/mL, 6.5 mg/mL, 10.0 mg, 2.0 %, 10.0 mg/mL, 28.2 mg/mL, 3.125 mg/mL
, Oral, Tablet, Tablet - Oral, Syrup, Syrup - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Suppository, Rectal, Suppository - Rectal, Injection, Injection - Intramuscular; Intravenous, Intramuscular, Injection - Intramuscular, Liquid, Liquid - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral, Injection, solution - Intramuscular, Intravenous, Injection, solution - Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Topical, Cream, Cream - Topical

Warnings

Phenergan Contraindications
Condition
Risk Level
Notes
subcutaneous route of administration
Do Not Combine
Asthma
Do Not Combine
Pulse Frequency
Do Not Combine
intra-arterial route of administration
Do Not Combine
Coma
Do Not Combine
lower respiratory tract symptoms
Do Not Combine
There are 20 known major drug interactions with Phenergan.
Common Phenergan Drug Interactions
Drug Name
Risk Level
Description
Acenocoumarol
Major
The metabolism of Acenocoumarol can be decreased when combined with Promethazine.
Aclidinium
Major
The risk or severity of adverse effects can be increased when Promethazine is combined with Aclidinium.
Amisulpride
Major
Promethazine may increase the antipsychotic activities of Amisulpride.
Astemizole
Major
The metabolism of Astemizole can be decreased when combined with Promethazine.
Azelastine
Major
Promethazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Phenergan Toxicity & Overdose RiskThe lowest toxic dose of promethazine in rats and mice is 170mg/kg and 160mg/kg intraperitoneally, and 400mg/kg and 240mg/kg subcutaneously. Taking too much promethazine can cause mild mental and heart problems, low blood pressure, slow breathing, loss of consciousness, stiff muscles, twitches, seizures, dry mouth, redness of the face, stomach problems, and a fixed gaze. Treating an overdose may involve taking activated charcoal, sulfates, controlled ventilation, diazepam, fluids, drugs to increase blood pressure, anti-Parkinson medications, diphenhyd
image of a doctor in a lab doing drug, clinical research

Phenergan Novel Uses: Which Conditions Have a Clinical Trial Featuring Phenergan?

131 active clinical trials are currently examining the potential of Phenergan in providing Allergy relief, Sedative therapy and Hay Fever mitigation.
Condition
Clinical Trials
Trial Phases
Anaphylaxis
2 Actively Recruiting
Phase 1
Motion Sickness
0 Actively Recruiting
Analgesics
2 Actively Recruiting
Phase 4
Rhinitis, Vasomotor
0 Actively Recruiting
Catarrh
0 Actively Recruiting
Nausea
0 Actively Recruiting
Dermographism
0 Actively Recruiting
Acute Bronchitis
5 Actively Recruiting
Phase 4, Not Applicable, Early Phase 1
upper respiratory symptoms
0 Actively Recruiting
Postoperative Pain
18 Actively Recruiting
Phase 4, Not Applicable, Phase 2, Phase 1, Early Phase 1, Phase 3
Allergic urticaria
0 Actively Recruiting
perioperative nausea and vomiting
0 Actively Recruiting
Sedative therapy
0 Actively Recruiting
Pain management
0 Actively Recruiting
Nasal Congestion
0 Actively Recruiting
Hypersensitivity
0 Actively Recruiting
Allergic Conjunctivitis (AC)
2 Actively Recruiting
Phase 3
Hay Fever
0 Actively Recruiting
Hypersensitivity
0 Actively Recruiting
Airsickness
4 Actively Recruiting
Phase 1, Not Applicable

Phenergan Reviews: What are patients saying about Phenergan?

5Patient Review
1/11/2014
Phenergan for Feel Like Throwing Up
I stopped taking this medication after only two days because it made me feel worse. I was constantly dizzy and sick, and couldn't keep anything down. It took a few more days to start feeling better, but I'm still dealing with some balance and dizziness issues.
5Patient Review
8/17/2013
Phenergan for Nausea and Vomiting
I had anaphylactic response and went to the ER as a result. Swelling made it difficult to speak or breathe.
5Patient Review
3/27/2017
Phenergan for Nausea and Vomiting
This was the only treatment that gave me relief when I had the stomach flu!
5Patient Review
12/27/2012
Phenergan for Nausea and Vomiting
5Patient Review
3/16/2014
Phenergan for Nausea and Vomiting
If you want this treatment to work, be sure to take it at least three or four hours before your planned bedtime.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about phenergan

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why does Phenergan make you sleepy?

"Promethazine blocks histamine receptors in the brain, which reduces symptoms. It also crosses the blood-brain barrier in large quantities, which can make you feel drowsy. Promethazine also blocks dopamine receptors, which prevents nausea."

Answered by AI

Is Phenergan a sedative?

"Phenergan may cause drowsiness in some people. A single dose may still affect you in the morning. Children and the elderly are especially sensitive to the effects of antihistamines."

Answered by AI

Is Phenergan good for sleep?

"Phenergan Night Time works by blocking histamine to help with insomnia and by working directly on the brain to help you feel more relaxed."

Answered by AI

What is a Phenergan used for?

"Phenergan Tablets are used as a short-term sleep aid for adults with difficulty sleeping, and to treat hay fever or hives in adults and children. They can also be used to treat nausea and vomiting, such as travel sickness."

Answered by AI

Clinical Trials for Phenergan

Have you considered Phenergan clinical trials? We made a collection of clinical trials featuring Phenergan, we think they might fit your search criteria.
Have you considered Phenergan clinical trials? We made a collection of clinical trials featuring Phenergan, we think they might fit your search criteria.
Have you considered Phenergan clinical trials? We made a collection of clinical trials featuring Phenergan, we think they might fit your search criteria.